China SXT Pharmaceuticals, Inc. (SXTC) Operating income 2017–2026
China SXT Pharmaceuticals, Inc. (SXTC) annual operating income history from SEC filings — each fiscal year as reported.
-$7.1MFY2026 · since FY2017: $1.6M → -$7.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$7.1M | -165.7% |
| FY2025 | -$2.7M | -6.6% |
| FY2024 | -$2.5M | +55.1% |
| FY2023 | -$5.6M | -8.1% |
| FY2022 | -$5.2M | -136.2% |
| FY2021 | -$2.2M | -63.8% |
| FY2020 | -$1.3M | -175.8% |
| FY2019 | $1.8M | +8.4% |
| FY2018 | $1.6M | +1.9% |
| FY2017 | $1.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice